Document ID: chunk:federal_register_of_legislation:F2024L01444:schedule:1:p1
Version: federal_register_of_legislation:F2024L01444
Segment Type: schedule
Provision Reference: sch 1 (pt 1/2)
Character Range: 1723–4998

Schedule 1—Amendments

Repatriation Pharmaceutical Benefits Scheme

   1.         Section 3
insert heading

         Definitions

   1.         Section 3, definition of Seventh Community Pharmacy Agreement
omit

   1.         Section 3, after definition of Drugs
insert

         Eighth Community Pharmacy Agreement means the written agreement of that name between the Commonwealth and The Pharmacy Guild of Australia about the delivery of PBS medicines and related services, as in force from time to time.

   1.         Paragraph 21A(2)(b)
omit

         Seventh Community Pharmacy Agreement
substitute

         Eighth Community Pharmacy Agreement

   1.         Subsection 21A(2) note
substitute

         Note: see clause 3 (Commonwealth Price) of the Eighth Community Pharmacy Agreement for the amounts mentioned above.

   1.         At the end of part 5
insert

         32A Additional community supply support payment

        1.            In this section:

         increased maximum quantity, of a Pharmaceutical benefit, means the maximum quantity or number of units of the benefit, or of a pharmaceutical item in the benefit, that may, in 1 prescription, be directed to be supplied on any 1 occasion, for a relevant purpose, under and in accordance with this Scheme or the Treatment Principles, part 5.7.
         increased maximum quantity prescription means a prescription directing the supply, on any 1 occasion, of the increased maximum quantity of a Pharmaceutical benefit.

NHA means the National Health Act 1953.

         NHA instrument means the instrument made under paragraph 98B(1)(b) of the NHA.
         relevant purpose, for a Pharmaceutical benefit, means a purpose, mentioned in the PBS Schedule or RPBS Schedule in relation to the benefit, that includes the phrase "The condition must be stable for the prescriber to consider the listed maximum quantity of this medicine suitable for this patient".

         Schedule equivalent—a Pharmaceutical benefit is Schedule equivalent to another Pharmaceutical benefit if the PBS Schedule or RPBS Schedule states that the benefits are equivalent.

          1.            The Commission is to pay an amount of money (an ACSS payment) to a Community Pharmacist for each supply by the pharmacist of a Pharmaceutical benefit:

                     1.            on or after 1 April 2024; and

             2.            under, and in accordance with, this Scheme or the Treatment Principles, part 5.7.

         unless the supply is a supply mentioned in paragraph 5(a), (b), (c), (d), (e) or (f) of the NHA instrument.

          1.            If an ACSS payment is payable for a supply, the amount of the payment is:

             1.            if subsection (4) or (5) applies to the supply—the amount mentioned in paragraph 6(1)(b) of the NHA instrument; or
             2.            in any other case—the amount mentioned in paragraph 6(1)(a) of the NHA instrument.

          1.            This subsection applies to a supply of a Pharmaceutical benefit to an Eligible Person for which an ACSS payment is payable if:

             1.            the supply is made upon an increased maximum quantity prescription directing the supply of:
                  1.                  the benefit; or